Clinical Trial Update: Study of SHR-1210 Combined With Apatinib in the Treatment of Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating SHR-1210 in combination with apatinib for sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Apatinib (apatinib)
• SHR-1210 (camrelizumab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Sarcoma | Phase 2 | Status: UNKNOWN